Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px
Organisation › Details

Debiopharm International S.A.

Debiopharm Group™ is a Swiss-based global biopharmaceutical group of five companies active in the development and manufacture of drugs and diagnostics tools. Debiopharm focuses on developing prescription drugs that target unmet medical needs. The group in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide. *

 

Period Start 2015-04-23 existent
  Group Debiopharm (Group)
Products Industry pharmaceutical
  Industry 2 drug development
Person Person Ducrey, Bertrand (Debiopharm 201610 CEO of Debiopharm International)
     
Region Region Lausanne VD
  Country Switzerland
  Street 5–7 Chemin Messidor
Forum »après-demain«
  City 1002 Lausanne VD
  Tel +41-21-321-0111
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Debiopharm International SA. (10/20/16). "Press Release: Debiopharm International SA Announces Clinical Collaboration with the Merck-Pfizer Alliance in Cancer Immunotherapy". Lausanne.
     
   
Record changed: 2020-03-31

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Debiopharm (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81




» top